Parallel Advisors, LLC Kodiak Sciences Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$6.52 - $8.05 $547 - $676	-84 Closed	0 $0
Q3 2022 Nov 10, 2022	BUY	$7.57 - $12.5 $635 - $1,050	84 New	84 $1,000
Q1 2021 Apr 23, 2021	SELL	$110.45 - $164.47 $773 - $1,151	-7 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$60.78 - $154.03 $425 - $1,078	7 New	7 $1,000
Q2 2020 Jul 16, 2020	SELL	$42.74 - $66.25 $7,308 - $11,328	-171 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$38.18 - $73.95 $6,528 - $12,645	171 New	171 $8,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $481M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.